Skip to Content

Primavax

Active Substance: diphtheria toxoid purified / hepatitis B, recombinant surface antigen / tetanus toxoid purified
Common Name: diphtheria, tetanus and hepatitis B vaccine, adsorbed
ATC Code: J07CA
Marketing Authorisation Holder: Pasteur Mèrieux MSD
Active Substance: diphtheria toxoid purified / hepatitis B, recombinant surface antigen / tetanus toxoid purified
Status: Withdrawn
Authorisation Date: 1998-02-05
Therapeutic Area: Hepatitis B Diphtheria Immunization Tetanus
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

This vaccine is indicated for active immunization against hepatitis B, caused by all known subtypes, diphtheria and tetanus in infants :
- for primary vaccination
- for booster
according to national vaccination policies.
This vaccine should not be administered to neonates.
This vaccine is not intended for use in adolescents or adults.

The marketing authorisation for Primavax has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide